Focus on Adoptive T Cell Transfer Trials in Melanoma

Adoptive Cell Transfer (ACT) of Tumor-Infiltrating Lymphocytes (TIL) in combination with lymphodepletion has proven to be an effective treatment for metastatic melanoma patients, with an objective response rate in 50%–70% of the patients. It is based on the ex vivo expansion and activation of tumor-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hershkovitz, Liat, Schachter, Jacob, Treves, Avraham J., Besser, Michal J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018069/
https://www.ncbi.nlm.nih.gov/pubmed/21234353
http://dx.doi.org/10.1155/2010/260267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018069/
https://www.ncbi.nlm.nih.gov/pubmed/21234353
http://dx.doi.org/10.1155/2010/260267

Ejemplares similares